Establishing an ANO1-Based Cell Model for High-Throughput Screening Targeting TRPV4 Regulators.

Area of Science:

• Pharmacology
• Molecular Biology
• Biophysics

Background:

• Transient Receptor Potential Vanilloid 4 (TRPV4) channels are crucial in physiological and pathological processes.
• Current TRPV4 drug development faces challenges due to side effects and limitations in high-throughput screening (HTS) methods.

Purpose of the Study:

• To establish a novel cell model and HTS method for identifying drugs targeting the TRPV4 channel.
• To overcome the limitations of existing screening techniques and facilitate efficient drug discovery for TRPV4-related conditions.

Main Methods:

• Development of a cell model utilizing calcium-activated chloride channel protein 1 (ANO1) and a yellow fluorescent protein (YFP) double mutant.
• Validation using patch-clamp and fluorescence quenching kinetic experiments to assess intracellular Ca2+ concentration changes.
• Evaluation of the model's functionality with temperature variations and TRPV4 modulators for HTS performance.

Main Results:

• The developed cell model demonstrated high sensitivity in detecting intracellular Ca2+ concentration fluctuations.
• The model proved effective for HTS, successfully screening TRPV4 drugs.
• The established system is well-suited for large-scale screening of potential TRPV4 therapeutics.

Conclusions:

• A robust cell-based drug screening model for the TRPV4 channel has been successfully constructed.
• This model offers a valuable tool for in vitro studies of TRPV4's pathophysiological roles.
• The developed HTS method enhances the efficiency and applicability of TRPV4 drug discovery.